NEW YORK (GenomeWeb) – Epigenomics today reported that its first quarter revenues dropped 10 percent year over year on lower product revenues.

The German molecular diagnostics firm reported revenues of €367,000 ($412,920) versus revenues of €407,000 for the first quarter of 2015. The company said that its product revenues declined 21 percent year over year to €169,000, but added in a statement that it has received initial product orders from China, which it believes will lead to higher revenue in the second half of the year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.